10-QHealthcare

Oscar Health, Inc.

OSCR · Period ending 2026-09-30 · Filed 2026-11-05 · Updated

In short

Oscar Health, Inc. (OSCR) has revenue up 27.5% to $11.7B and operating cash flow up 11.9% to $1.1B year on year. Its net margin is -3.8%, and it trades at 25.7× trailing earnings. Fisclear flags 1 high-severity risk, led by: Net loss of $443.2M — the company spent more than it earned. Investors should monitor the path to profitability. How we calculate this

Valuation

Healthcare
Live · Yahoo Finance

Price

$24.73

P/E (TTM)

11.0x

Price ÷ earnings per share

P/B

3.5x

Price ÷ book value

P/S (TTM)

0.4x

Price ÷ revenue per share

Beta

2.49

High volatility vs market

52-Week Range

$10.69$24.73 now$38.50

Decision Context

Altman Z-Score indicates financial distress risk. Review debt levels and cash runway before any position sizing decision.

Based on filing period ending Sept 2026

FisclearScore is a quantitative model using public financial data and sector median benchmarks (refreshed monthly). Not financial advice. Always conduct independent due diligence.

OSCR vs

Macro Context

Fed Funds Rate

3.88%

Accommodative

10-Year Treasury

5.13%

2026-10-01

Unemployment

4.2%

Near full employment

CPI Index

336.3

2026-09-01

M2 Money Supply

$23.4T

2026-09-01

The Federal Funds rate stands at 3.88% — a moderately elevated rate environment that raises borrowing costs across the economy; 10-year Treasury yields are at 5.13%, setting the benchmark for long-term corporate borrowing; Unemployment stands at 4.2%; Industrial production index is at 104.0; M2 money supply is $23.4T; CPI index stands at 336.3.

SWOT Analysis — OSCR

Inflationary Boom
Macro lens (Inflationary Boom): Rising costs and tighter margins amplify financial risks in this regime.
✦

Strengths

  • Total Assets: $6.3B (+30.7% YoY) — Total assets grew 31% — the company's resource base expanded.

  • Revenue: $11.7B (+27.5% YoY) — Revenue grew 28% — the company sold more goods or services than the prior year.

  • Operating Cash Flow: $1.1B (+11.9% YoY) — Operating cash flow grew 12% — the business generated more cash from day-to-day operations.

◈

Weaknesses

  • Net Income: -$443.2M (-1842.5% YoY) — The company posted a net loss — total expenses exceeded total revenue.

  • EPS (Diluted): $-1.69 (-1790.0% YoY) — Negative EPS — the company recorded a loss on a per-share basis.

  • Beta of 2.49x — this stock moves significantly more than the broader market, amplifying both gains and drawdowns.

◎

Opportunities

No clear opportunities identified at this time.

⚠

Threats

  • Net loss of $443.2M — the company spent more than it earned. Investors should monitor the path to profitability.

Year-over-Year Changes

Net Income

-$443.2M

was $25.4M

−1842.5%

The company posted a net loss — total expenses exceeded total revenue.

EPS (Diluted)

$-1.69

was $0.10

−1790.0%

Negative EPS — the company recorded a loss on a per-share basis.

Total Assets

$6.3B

was $4.8B

+30.7%

Total assets grew 31% — the company's resource base expanded.

Revenue

$11.7B

was $9.2B

+27.5%

Revenue grew 28% — the company sold more goods or services than the prior year.

Operating Cash Flow

$1.1B

was $978.2M

+11.9%

Operating cash flow grew 12% — the business generated more cash from day-to-day operations.

Risk Flags

1 high · 0 medium · 1 low
  • ⚠ High

    Net loss of $443.2M — the company spent more than it earned. Investors should monitor the path to profitability.

  • ○ Low

    Beta of 2.49x — this stock moves significantly more than the broader market, amplifying both gains and drawdowns.

Technical Signals

Daily closes · 1-year data

Oscar Health, Inc.: common questions

Is Oscar Health, Inc. profitable?

No. Oscar Health, Inc. reported a net loss of $443M in its latest fiscal year (fiscal 2025), a net margin of -3.8%.

Is Oscar Health, Inc.'s revenue growing?

Yes. Revenue grew 27.5% year on year, to $11.7B.

What is Oscar Health, Inc.'s P/E ratio?

Oscar Health, Inc. trades at 11.0× its trailing twelve-month earnings. In other words, the share price is about 11 times the profit per share the company earned over the past year.

Does Oscar Health, Inc. pay a dividend?

No dividend is currently expected from Oscar Health, Inc., according to the latest market data.

What are the main risks for Oscar Health, Inc.?

Fisclear's checks flag 1 medium- or high-severity risk. The most serious: Net loss of $443.2M — the company spent more than it earned. Investors should monitor the path to profitability.

Answers are generated from the figures in this report (updated 6 Nov 2026). Information, not investment advice.

Latest News

via Finnhub

Filing History — OSCR

Get the weekly digest

5 company reports + macro context every week, free. No spam.

  • Unlimited goal simulations
  • 5 free company report summaries per day
  • Weekly financial insights newsletter

External Links

Trade OSCR

Links open broker research pages. Not an endorsement or recommendation.

Research Oscar Health, Inc.

Data sourced from SEC EDGAR, FRED (Federal Reserve Economic Data), and Yahoo Finance. For informational purposes only. Not financial advice.